Literature DB >> 19574340

Post-menopausal hormone use and albuminuria.

Emily L Schopick1, Naomi D Fisher, Julie Lin, John P Forman, Gary C Curhan.   

Abstract

BACKGROUND: Higher levels of urinary albumin excretion predict future hypertension and chronic kidney disease. Post-menopausal hormone use may influence the renin-angiotensin system and renal endothelial function, impacting albumin excretion. The association between post-menopausal hormone use and albuminuria is not well defined.
METHODS: We explored the cross-sectional association between duration of PMH use and albuminuria in 2445 post-menopausal, non-diabetic women from the Nurses' Health Study. Women were categorized as hormone non-users, past users or current users grouped by 3-year intervals of duration of use, from < or =3 years to >15 years. The outcome was the top decile of urine albumin/creatinine ratio (ACR). Multivariate logistic regression was used to assess the association between duration of PMH use and risk of being in the top decile.
RESULTS: The mean age was 66.8 years, and 57% were currently using PMH. The median ACR was 2.9 mg/g, and the 90th percentile was 9.2 mg/g. Compared with women with no history of PMH use, the odds ratio for being in the top ACR decile was lower for women with use of >6-9 years, >9-12 years, >12-15 years and >15 years, but there was no dose-response. The overall odds ratio was 0.55 (95% CI: 0.39-0.77) among women with >6 years of current PMH use compared with non-users. Current hormone use of shorter duration and past hormone use were not associated with albumin excretion.
CONCLUSIONS: Current PMH use of >6 years is associated with a lower urinary ACR in non-diabetic women.

Entities:  

Mesh:

Year:  2009        PMID: 19574340      PMCID: PMC2790951          DOI: 10.1093/ndt/gfp321

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  29 in total

Review 1.  Renal handling of albumin: a critical review of basic concepts and perspective.

Authors:  Leileata M Russo; George L Bakris; Wayne D Comper
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

2.  HRT does not improve urinary albumin excretion in postmenopausal diabetic women.

Authors:  Patrick J Manning; Wayne H F Sutherland; Anne R Allum; Sylvia A de Jong; Shirley D Jones
Journal:  Diabetes Res Clin Pract       Date:  2003-04       Impact factor: 5.602

3.  The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.

Authors:  Veysel Fenkci; Mehmet Yilmazer; Mete Alpaslan; Ersel Onrat; Semin Fenkci
Journal:  Gynecol Obstet Invest       Date:  2003       Impact factor: 2.031

4.  First morning voids are more reliable than spot urine samples to assess microalbuminuria.

Authors:  Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

5.  Estradiol is nephroprotective in the rat remnant kidney.

Authors:  Balazs Antus; Peter Hamar; Gabor Kokeny; Zoltan Szollosi; Istvan Mucsi; Zoltan Nemes; Laszlo Rosivall
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

6.  Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race.

Authors:  Holly J Mattix; Chi-Yuan Hsu; Shimon Shaykevich; Gary Curhan
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

7.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

8.  Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

Authors:  T B Monster; W M Janssen; P E de Jong; L T de Jong-van den Berg
Journal:  Arch Intern Med       Date:  2001-09-10

9.  Hormone replacement therapy and breast cancer risk in a nationally representative cohort.

Authors:  J F Lando; K E Heck; K M Brett
Journal:  Am J Prev Med       Date:  1999-10       Impact factor: 5.043

10.  Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion.

Authors:  Sofia B Ahmed; Amrit K Kang; Kevin D Burns; Christopher R J Kennedy; Vesta Lai; Daniel C Cattran; James W Scholey; Judith A Miller
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

View more
  11 in total

1.  Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.

Authors:  Catherine Kim; Ana C Ricardo; Edward J Boyko; Costas A Christophi; Marinella Temprosa; Karol E Watson; Xavier Pi-Sunyer; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

2.  Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Emma H Trimmer; Shreya N Kashyap; Jennifer L Duong; Brennah Murphy; Elin M Grissom; Jill M Daniel; Sarah H Lindsey
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-09

Review 3.  The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.

Authors:  Sebastian Kummer; Gero von Gersdorff; Markus J Kemper; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

4.  A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.

Authors:  Maple M Fung; Sameer Poddar; Ricki Bettencourt; Simerjot Kaur Jassal; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

5.  Physical activity and albuminuria.

Authors:  Emily S Robinson; Naomi D Fisher; John P Forman; Gary C Curhan
Journal:  Am J Epidemiol       Date:  2010-02-04       Impact factor: 4.897

6.  Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis.

Authors:  Andrea G Kattah; Maria L G Suarez; Natasa Milic; Kejal Kantarci; Burcu Zeydan; Thomas Mosley; Stephen T Turner; Erin B Ware; Sharon L R Kardia; Vesna D Garovic
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

7.  CKD in Patients with Bilateral Oophorectomy.

Authors:  Andrea G Kattah; Carin Y Smith; Liliana Gazzuola Rocca; Brandon R Grossardt; Vesna D Garovic; Walter A Rocca
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-19       Impact factor: 8.237

8.  Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.

Authors:  Sebastian Kummer; Stefanie Jeruschke; Lara Vanessa Wegerich; Andrea Peters; Petra Lehmann; Annette Seibt; Friederike Mueller; Nadezda Koleganova; Elisabeth Halbenz; Claus Peter Schmitt; Markus Bettendorf; Ertan Mayatepek; Marie-Luise Gross-Weissmann; Jun Oh
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

9.  Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' Perceptions.

Authors:  Sharanya Ramesh; Matthew T James; Jayna M Holroyd-Leduc; Stephen B Wilton; Ellen W Seely; David C Wheeler; Sofia B Ahmed
Journal:  Can J Kidney Health Dis       Date:  2017-10-27

10.  Association between Urine Albumin-to-Creatinine Ratio within the Normal Range and Incident Hypertension in Men and Women.

Authors:  Dhananjay Yadav; Dae Ryong Kang; Sang Baek Koh; Jang Young Kim; Song Vogue Ahn
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.